Clinical Trial Update: Selective Neoadjuvant Treatment According to Immunohistochemical Subtype for HER2 Negative Breast Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating selective neoadjuvant treatment by immunohistochemical subtype for HER2-negative breast cancer patients; results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Spanish Breast Cancer Research Group | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2019-07-17